The UK has agreed to a pharma deal with the US

The government has agreed to a major deal with Washington that will see the UK become the only country to secure zero import tariffs on pharmaceutical products into the US for at least three years.

The deal follows months of negotiations between the government and the Trump administration, after the June trade deal left the future of pharmaceutical exports in the dark and the President threatened to raise tariffs to as high as 100 per cent on branded drug imports.

The agreement will also secure “preferential terms” for the UK’s medtech exports, meaning no additional tariffs will be added on top of the current 10 per cent.

Business and trade secretary, Peter Kyle, said: “This deal guarantees that UK pharmaceutical exports, worth at least £5

See Full Page